Who is sponsoring NCT03465683?

NCT03465683 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT03465683?

Interventions in NCT03465683: ESBL-producing Enterobacteriaceae.

What condition does NCT03465683 study?

NCT03465683 studies Hospital Acquired Infection.

Is NCT03465683 still recruiting?

NCT03465683 is currently recruiting now. Last updated 17 November 2025.

Last reviewed 2025-11-17 · How we verify

NCT03465683

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transmission of ESBL-producing Enterobacteriaceae

Recruiting now Last updated 17 November 2025

What this trial tests

trial testing ESBL-producing Enterobacteriaceae in Hospital Acquired Infection in 2,000 participants. Currently enrolling.

Timeline

1 March 2017

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	1 March 2017
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across Switzerland

Drugs / interventions tested

ESBL-producing Enterobacteriaceae

Conditions studied

Hospital Acquired Infection — all drugs for Hospital Acquired Infection →

Sponsor

University Hospital, Basel, Switzerland

Who can join

1 and older, any sex, with Hospital Acquired Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this research project is to investigate the transmission of ESBL-producing Enterobacteriaceae on both, the level of bacterial strains and mobile genetic elements, and to determine the source of hospital-acquired infections.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Within-host genetic diversity of extended-spectrum beta-lactamase-producing Enterobacterales in long-term colonized patients.
Aguilar-Bultet L, García-Martín AB, Vock I, Maurer Pekerman L, et al · · 2023 · cited 11× · PMID 38129423 · DOI 10.1038/s41467-023-44285-w
Spatiotemporal dissemination of ESBL-producing Enterobacterales in municipal sewer systems: a prospective, longitudinal study in the city of Basel, Switzerland.
Gómez-Sanz E, Bagutti C, Roth JA, Alt Hug M, et al · · 2023 · cited 10× · PMID 37250050 · DOI 10.3389/fmicb.2023.1174336
Extended-spectrum β-lactamase-producing Enterobacterales in diverse foodstuffs: a prospective, longitudinal study in the city of Basel, Switzerland.
Gómez-Sanz E, Bagutti C, García-Martín AB, Roth JA, et al · · 2023 · cited 6× · PMID 38075908 · DOI 10.3389/fmicb.2023.1295037
Identification of a Cluster of Extended-spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Sequence Type 101 Isolated From Food and Humans.
Aguilar-Bultet L, Bagutti C, Egli A, Alt M, et al · · 2021 · cited 3× · PMID 32776135 · DOI 10.1093/cid/ciaa1164

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03465683 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 17 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03465683.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing